Literature DB >> 15383695

Altered diurnal variation of nitric oxide production in patients with panic disorder.

Burhanettin Kaya1, Süheyla Unal, Aysun Bay Karabulut, Yusuf Türköz.   

Abstract

The aim of this prospective study was to investigate the diurnal change in serum nitric oxide (NO) levels in active and remission phases of patients with panic disorder. This study included 15 patients fulfilling the criteria for panic disorder of Diagnostic and Statistical Manual of Mental Disorders--Fourth Edition and 15 healthy controls matched for age and sex. All patients were receiving a selective serotonin reuptake inhibitor at therapeutic doses. The serum nitrite and nitrate levels of subjects were determined at 10:00 a.m. after overnight fasting and at 3:00 p.m. 2 hours after lunch. NO levels of all patients measured in the morning were significantly higher than those of controls. The patients were also divided into active and remission groups according to clinical status and Panic Agoraphobia Scale's cut-off point. There were no statistically significant differences in serum nitrite and nitrate levels of the active group between the 10:00 a.m. and 3:00 p.m. measurements. In contrast, statistically significant differences were found in the serum levels of nitrite (p<0.05) and nitrate (p<0.05) in the remission group. Notably, the afternoon nitrite and nitrate levels of the remission group were higher than those of the morning levels as seen in control subjects. Thus, diurnal variation of NO production is altered in patients with panic disorder but is resumed in the remission phase. The present study suggests that serum NO levels are a good marker for evaluation of panic disorder. Copyright 2004 Tohoku University Medical Press

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383695     DOI: 10.1620/tjem.204.147

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  3 in total

1.  Body temperature in patients with panic disorder treated with escitalopram.

Authors:  Doron Todder; Michael Fox; Bernhard T Baune
Journal:  Clin Auton Res       Date:  2009-05-29       Impact factor: 4.435

2.  Candidate SNP Markers of Chronopathologies Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.

Authors:  Petr Ponomarenko; Dmitry Rasskazov; Valentin Suslov; Ekaterina Sharypova; Ludmila Savinkova; Olga Podkolodnaya; Nikolay L Podkolodny; Natalya N Tverdokhleb; Irina Chadaeva; Mikhail Ponomarenko; Nikolay Kolchanov
Journal:  Biomed Res Int       Date:  2016-08-22       Impact factor: 3.411

3.  Alterations of oral microbiota in patients with panic disorder.

Authors:  Zunli Xie; Weiqing Jiang; Mingzhu Deng; Wei Wang; Xian Xie; Xia Feng; Yinping Shi; Xueyan Zhang; Dong Song; Ziyu Yuan; Yonggang Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.